Pharm-Olam LLC, announced the deployment of Medidata Rave® to streamline its global Data Management and Reporting services.
JANUARY 31, 2017
HOUSTON, TEXAS – January 31, 2017. Pharm-Olam International Ltd., a multinational, full-service clinical research organization (CRO) serving the biopharmaceutical and medical device industries, today announced that it has deployed Medidata Rave (link is external)®—the industry’s leading electronic data capture (EDC), management and reporting tool—to streamline its global Data Management and Reporting services. Part of the Medidata Clinical Cloud (link is external)® platform, Rave is a highly scalable, unified SaaS solution that enables users to manage clinical data from multiple sources, as well as quickly analyze and extract information for real-time decision-making throughout a clinical trial.
“As part of our ongoing efforts to implement a fully integrated data management method, Pharm-Olam is leveraging Medidata Rave to power our strategic data management initiatives,” said Sanjiv Suri, Pharm-Olam Chief Executive Officer. “We’ve been hard at work, over the past 12 months especially, refining our Data Management offering. A sophisticated software platform is critical to our long-term success, and we need something proven, scalable and comprehensive. That’s why we selected Medidata Rave.”
Renee Hart, Senior Vice President of Global Partners at Medidata, said: “Medidata is delighted to forge this new relationship with Pharm-Olam, a forward-thinking organization whose operational and therapeutic expertise is driving medical innovation and hope for patients,” said Hart. “We look forward to working with the Pharm-Olam team, providing them with the tools and resources needed to be successful on a global scale.”
Suri added: “Rave provides our team with the capabilities to manage every aspect of a sponsor’s data requirements, and monitor a development program’s status across every time zone.”
Pharm-Olam operates in more than 60 countries worldwide, offering end-to-end clinical trial support for Phase I-IV clinical trials. More information about Pharm-Olam and its full-service capabilities and offerings are available at www.pharm-olam.com, or you may contact us via email at info@pharm-olam.com (link sends e-mail).
About Pharm-Olam International Group
Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines, making clinical research as Easy As I, II, III, IV™. For further information about Pharm-Olam, please visit www.pharm-olam.com.
About Medidata
Medidata (link is external) is reinventing global drug development by creating the industry’s leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 800 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 17 of the world’s top 25 global pharmaceutical companies, from study design and planning through execution, management and reporting.